scholarly journals Genotyping Error Detection Through Tightly Linked Markers

Genetics ◽  
2003 ◽  
Vol 164 (3) ◽  
pp. 1161-1173
Author(s):  
Guohua Zou ◽  
Deyun Pan ◽  
Hongyu Zhao

Abstract The identification of genotyping errors is an important issue in mapping complex disease genes. Although it is common practice to genotype multiple markers in a candidate region in genetic studies, the potential benefit of jointly analyzing multiple markers to detect genotyping errors has not been investigated. In this article, we discuss genotyping error detections for a set of tightly linked markers in nuclear families, and the objective is to identify families likely to have genotyping errors at one or more markers. We make use of the fact that recombination is a very unlikely event among these markers. We first show that, with family trios, no extra information can be gained by jointly analyzing markers if no phase information is available, and error detection rates are usually low if Mendelian consistency is used as the only standard for checking errors. However, for nuclear families with more than one child, error detection rates can be greatly increased with the consideration of more markers. Error detection rates also increase with the number of children in each family. Because families displaying Mendelian consistency may still have genotyping errors, we calculate the probability that a family displaying Mendelian consistency has correct genotypes. These probabilities can help identify families that, although showing Mendelian consistency, may have genotyping errors. In addition, we examine the benefit of available haplotype frequencies in the general population on genotyping error detections. We show that both error detection rates and the probability that an observed family displaying Mendelian consistency has correct genotypes can be greatly increased when such additional information is available.

BMC Genetics ◽  
2003 ◽  
Vol 4 (Suppl 1) ◽  
pp. S40 ◽  
Author(s):  
Michael D Badzioch ◽  
Hawkins B DeFrance ◽  
Gail P Jarvik

The Lancet ◽  
2005 ◽  
Vol 366 (9492) ◽  
pp. 1223-1234 ◽  
Author(s):  
Lyle J Palmer ◽  
Lon R Cardon

2005 ◽  
Vol 19 (10) ◽  
pp. 603-606 ◽  
Author(s):  
Hugh J Freeman

Erythema nodosum and pyoderma gangrenosum may occur in Crohn's disease. In the present evaluation of consecutive patients with Crohn's disease spanning more than two decades, erythema nodosum was seen in 45 patients and pyoderma gangrenosum was seen in seven patients. Forty-one of 566 women (7.2%) and nine of 449 men (2.0%) were affected. Of these, 45 (4.4%) had erythema nodosum and seven (0.7%) had pyoderma gangrenosum, including two (0.2%) with both dermatological disorders at different times during their clinical courses. Recurrent erythema nodosum was also detected in nine patients (20%) including eight women, while recurrent pyoderma gangrenosum was seen in two patients (28.6%). There was an age-dependent effect on the appearance of erythema nodosum in women, with the highest percentages seen in those younger than 20 years of age. Detection rates for erythema nodosum in women only approached the low mens' rates in Crohn's disease at older than 40 years of age. Most patients with these dermatological disorders had colonic disease with or without ileal involvement as well as complex disease, usually with penetrating complications. The present study documents a sex-based and age-dependent effect on the clinical expression of erythema nodosum in Crohn's disease. This suggests that some components of the inflammatory process in Crohn's disease may be modulated by estrogen-mediated events, particularly in adolescents and young adults.


Genes ◽  
2019 ◽  
Vol 10 (2) ◽  
pp. 143 ◽  
Author(s):  
Xiaohui Zhao ◽  
Zhi-Ping Liu

Network biology and medicine provide unprecedented opportunities and challenges for deciphering disease mechanisms from integrative viewpoints. The disease genes and their products perform their dysfunctions via physical and biochemical interactions in the form of a molecular network. The topological parameters of these disease genes in the interactome are of prominent interest to the understanding of their functionality from a systematic perspective. In this work, we provide a systems biology analysis of the topological features of complex disease genes in an integrated biomolecular network. Firstly, we identify the characteristics of four network parameters in the ten most frequently studied disease genes and identify several specific patterns of their topologies. Then, we confirm our findings in the other disease genes of three complex disorders (i.e., Alzheimer’s disease, diabetes mellitus, and hepatocellular carcinoma). The results reveal that the disease genes tend to have a higher betweenness centrality, a smaller average shortest path length, and a smaller clustering coefficient when compared to normal genes, whereas they have no significant degree prominence. The features highlight the importance of gene location in the integrated functional linkages.


Author(s):  
Eric S Kilpatrick

Background Even when a laboratory analyte testing process is in control, routine quality control testing will fail with a frequency that can be predicted by the number of quality control levels used, the run frequency and the control rule employed. We explored whether simply counting the number of assay quality control run failures during a running week, and then objectively determining if there was an excess, could complement daily quality control processes in identifying an out-of-control assay. Methods Binomial statistics were used to determine the threshold number of quality control run failures in any rolling week which would statistically exceed that expected for a particular test. Power function graphs were used to establish error detection (Ped) and false rejection rates compared with popular control rules. Results Identifying quality control failures exceeding the weekly limit (QC FEWL) is a more powerful means of detecting smaller systematic (bias) errors than traditional daily control rules (12s, 13s or 13s/22s/R4s) and markedly superior in detecting smaller random (imprecision) errors while maintaining false identification rates below 2%. Error detection rates also exceeded those using a within- and between-run Westgard multirule (13s/22s/41s/10x). Conclusions Daily review of tests shown to statistically exceed their rolling week limit of expected quality control run failures is more powerful than traditional quality control tools at identifying potential systematic and random test errors and so offers a supplement to daily quality control practices that has no requirement for complex data extraction or manipulation.


2017 ◽  
Vol 48 (04) ◽  
pp. 282-293 ◽  
Author(s):  
Michaela Auer-Grumbach ◽  
Jan Senderek ◽  
Sabine Rudnik-Schöneborn

AbstractHereditary neuropathy is an umbrella term for a group of nonsyndromic conditions with a prevalence of approximately 1:2,500. In addition to the most frequent form, Charcot–Marie–Tooth's disease (CMT, or hereditary motor and sensory neuropathy), there are additional entities such as hereditary neuropathy with liability to pressure palsies (HNPP), hereditary motor neuropathies (HMNs), and hereditary sensory and autonomic neuropathies (HSANs). With the exception of HNPP, which is almost always caused by defects of the PMP22 gene, all other forms show genetic heterogeneity with altogether close to 100 genes involved. Mutation detection rates vary considerably, reaching up to 80% in demyelinating CMT (CMT1) but are still as low as 10 to 30% in axonal CMT (CMT2), HMN, and HSAN. Based on current information, analysis of only four genes (PMP22, GJB1, MPZ, MFN2) identifies 80 to 90% of CMT-causing mutations that can be detected in all known disease genes. For the remaining patients, parallel analysis of multiple neuropathy genes using next-generation sequencing is now replacing phenotype-oriented multistep gene-by-gene sequencing. Such approaches tend to generate a wealth of genetic information that requires comprehensive evaluation of the pathogenic relevance of identified variants. In this review, we present current classification systems, specific phenotypic clues, and genetic testing algorithms in the different subgroups of hereditary neuropathies.


2006 ◽  
Vol 30 (2) ◽  
pp. 143-154 ◽  
Author(s):  
Wen-Harn Pan ◽  
Ke-Shiuan Lynn ◽  
Chun-Houh Chen ◽  
Yi-Lin Wu ◽  
Chung-Yen Lin ◽  
...  

2015 ◽  
Vol 5 (1) ◽  
Author(s):  
Jialiang Yang ◽  
◽  
Tao Huang ◽  
Francesca Petralia ◽  
Quan Long ◽  
...  

Abstract Aging is one of the most important biological processes and is a known risk factor for many age-related diseases in human. Studying age-related transcriptomic changes in tissues across the whole body can provide valuable information for a holistic understanding of this fundamental process. In this work, we catalogue age-related gene expression changes in nine tissues from nearly two hundred individuals collected by the Genotype-Tissue Expression (GTEx) project. In general, we find the aging gene expression signatures are very tissue specific. However, enrichment for some well-known aging components such as mitochondria biology is observed in many tissues. Different levels of cross-tissue synchronization of age-related gene expression changes are observed and some essential tissues (e.g., heart and lung) show much stronger “co-aging” than other tissues based on a principal component analysis. The aging gene signatures and complex disease genes show a complex overlapping pattern and only in some cases, we see that they are significantly overlapped in the tissues affected by the corresponding diseases. In summary, our analyses provide novel insights to the co-regulation of age-related gene expression in multiple tissues; it also presents a tissue-specific view of the link between aging and age-related diseases.


2021 ◽  
Author(s):  
Helen Overhoff ◽  
Yiu Hong Ko ◽  
Daniel Feuerriegel ◽  
Gereon R. Fink ◽  
Jutta Stahl ◽  
...  

Metacognitive accuracy describes the degree of overlap between the subjective perception of one's decision accuracy (i.e., confidence) and objectively observed performance. With older age, the need for accurate metacognitive evaluation increases; however, error detection rates typically decrease. We investigated the effect of ageing on metacognitive accuracy using event-related potentials (ERPs) reflecting error detection and confidence: the error/correct negativity (Ne/c) and the error/correct positivity (Pe/c). Sixty-five healthy adults (20 to 76 years) completed a complex perceptual task and provided confidence ratings. We found that metacognitive accuracy declined with age beyond the expected decline in task performance, while the adaptive adjustment of behaviour was well preserved. Pe/c amplitudes varied by confidence rating, but they did not mirror the reduction in metacognitive accuracy. Ne/c amplitudes decreased with age except for high confidence correct responses. The results suggest that age-related difficulties in metacognitive evaluation could be related to an impaired integration of decision accuracy and confidence information processing. Ultimately, training the metacognitive evaluation of fundamental decisions in older adults might constitute a promising endeavour.


Sign in / Sign up

Export Citation Format

Share Document